CYP11B1 | Cytochrome P450, family 11, subfamily B, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CYP11B2 | Cytochrome P450, family 11, subfamily B, polypeptide 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
HSD3B2 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP21A2 | Cytochrome P450, family 21, subfamily A, polypeptide 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MC2R | Melanocortin 2 receptor (adrenocorticotropic hormone) | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enriched |
TH | Tyrosine hydroxylase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
NOV | Nephroblastoma overexpressed | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ARHGAP36 | Rho GTPase activating protein 36 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP17A1 | Cytochrome P450, family 17, subfamily A, polypeptide 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PNMT | Phenylethanolamine N-methyltransferase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CHGB | Chromogranin B (secretogranin 1) | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
C18orf42 | Chromosome 18 open reading frame 42 | Predicted intracellular proteins
| | | | | Tissue enriched |
PHOX2A | Paired-like homeobox 2a | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
DBH | Dopamine beta-hydroxylase (dopamine beta-monooxygenase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FDX1 | Ferredoxin 1 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
STAR | Steroidogenic acute regulatory protein | Disease related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enriched |
DRGX | Dorsal root ganglia homeobox | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
UCP1 | Uncoupling protein 1 (mitochondrial, proton carrier) | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
VWA5B2 | Von Willebrand factor A domain containing 5B2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FAM19A4 | Family with sequence similarity 19 (chemokine (C-C motif)-like), member A4 | Predicted secreted proteins
| | | | | Tissue enriched |
MGARP | Mitochondria-localized glutamic acid-rich protein | Predicted membrane proteins
| | | | | Tissue enriched |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
DGKK | Diacylglycerol kinase, kappa | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
PHOX2B | Paired-like homeobox 2b | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
SLC18A1 | Solute carrier family 18 (vesicular monoamine transporter), member 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AS3MT | Arsenite methyltransferase | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
CARTPT | CART prepropeptide | FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CHRNA3 | Cholinergic receptor, nicotinic, alpha 3 (neuronal) | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
MAP3K15 | Mitogen-activated protein kinase kinase kinase 15 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
MCOLN3 | Mucolipin 3 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
NEUROD4 | Neuronal differentiation 4 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
KCNK2 | Potassium channel, subfamily K, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
KIAA1024 | KIAA1024 | Predicted membrane proteins
| | | | | Tissue enriched |
GJD2 | Gap junction protein, delta 2, 36kDa | Predicted membrane proteins
| | | | | Tissue enriched |
NTRK1 | Neurotrophic tyrosine kinase, receptor, type 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |